About this resource:
Source: The Cochrane Collaborative
Last Reviewed: June 2017
Workgroups: Arthritis Workgroup
In this Cochrane systematic review, the Cochrane Collaborative found that celecoxib, a selective non-steroidal anti-inflammatory drug (NSAID), may ease pain in people with rheumatoid arthritis (RA). The review included trials that compared celecoxib with a placebo or a traditional NSAID for people with RA (mostly women). Researchers found that after 12 weeks, people who took celecoxib had less pain than people who took a placebo and that results about physical function improvements were inconclusive in these groups. In studies comparing celecoxib to traditional NSAIDs, results about improvements in pain and physical function were also inconclusive.
Objectives related to this resource (1)
Fidahic, M., Jelicic Kadic, A., Radic, M. & Puljak, L. Celecoxib for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2017 (6). DOI: 10.1002/14651858.CD012095.pub2.